Ilika plc grants options under the Long Term Incentive Plan

Ilika

Ilika Plc (LON:IKA), a pioneer in solid-state battery technology, has announced that on 28 February 2023 it granted options to Executive Directors and employees under the Long Term Incentive Plan approved by shareholders in 2018 and the EMI scheme.

LTIP

Ilika awarded nominal value options under the LTIP over 416,954 ordinary shares of 1p each in the Company to an Executive Director and options over a further 2,800 Ordinary Shares to employees. Each award vests on the achievement of certain performance targets over a three-year period. 

EMI option scheme

Ilika plc granted market value options over 802,248 ordinary shares of 1p each in the Company to an Executive Director and employees under the Company EMI option scheme.  EMI options vest on the achievement of certain performance targets over a three-year period. 

The awards are intended to align the incentives of the Executive Directors and other senior employees with the Company’s performance and outcomes for shareholders over the long term and to provide effective and attractive levels of reward, based on delivering strong performance in a fair and proportionate manner.

In total, options over 1,222,002 Ordinary Shares have been granted representing 0.77% of issued share capital.

Details of grants issued under the LTIP and EMI option scheme by each Executive Director are set out in the table below, together with the total number of Ordinary Shares each Executive Director holds under option and is interested in.

DirectorNumber of options grantedScheme under which options grantedTotal number of Options now heldPer cent. of issued share capital
Graeme Purdy416,954LTIP2,779,0671.76
Jason Stewart300,000EMI300,0000.19

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika completes PRIMED programme with improved Goliath battery performance

Ilika has completed its £3 million PRIMED programme, reporting improved energy density, charging, power, cycle life and thermal stability for its 10Ah Goliath solid-state battery cells, alongside new commercial opportunities in defence, e-bikes and other applications.

Ilika to present UK-developed quasi-solid-state cell technology at Faraday Event

Ilika will present its UK-developed quasi-solid-state cell technology at The Faraday Institution’s Next Frontiers in Energy Storage event on Tuesday 8 September.

Ilika targets MedTech adoption with Stereax solid-state batteries

Ilika is targeting medical device and IoT applications with its Stereax miniature solid-state batteries, supported by a manufacturing and commercialisation agreement with Cirtec Medical.

Ilika confirms AGM date and Annual Report posting

Ilika has given notice of its 2026 Annual General Meeting and said its annual report and AGM notice will be available shortly.

Ilika targets medical device opportunities with Stereax at MedTech Ireland

Ilika’s Stereax technology will be presented at MedTech Ireland 2026 as the company targets further opportunities in active implanted medical devices.

Search